Clinical trial
A Randomized, Double-Blind, Placebo-Controlled Ascending Multiple Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VTP-43742 in Healthy Volunteers and Psoriatic Patients and Clinical Proof-of-Concept in Psoriatic Patients
NCT02555709 is registered in ClinicalTrials.gov with Vitae Pharmaceuticals Inc., an Allergan affiliate as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind, Placebo-Controlled Ascending Multiple Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VTP-43742 in Healthy Volunteers and Psoriatic Patients and Clinical Proof-of-Concept in Psoriatic Patients
- Lead sponsor
- Vitae Pharmaceuticals Inc., an Allergan affiliate
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- August 31, 2015
- Completion date
- March 31, 2016
- Enrollment
- 74 (actual)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.